Please login to the form below
anaesthetics
This page shows the latest anaesthetics news and features for those working in and with pharma, biotech and healthcare.
AcelRX’s potent opioid tablets set to win FDA backing for pain relief
Evaluating the safety and effectiveness of products for use in anaesthesiology and surgery, the Anaesthetic and Analgesic Drug Products Advisory Committee voted 10 to 3 in favour of the drug.
Latest news
-
Heron boosted by new data for ‘breakthrough’ pain drug
Heron Pharma has new data on its combination anaesthetic drug, and a breakthrough designation from the FDA, which suggests it could have an impact on the post-operative pain market. ... Heron’s rival candidate – called HTX-011 – pairs up a new
-
Iontas gets UK backing for chronic pain antibody project
to the central nervous system and are blocked by some local anaesthetics such as lidocaine.
-
It’s all about patient outcomes… right?
In late 1846, a dentist from New England, William TG Morton, is attributed to have performed a dental extraction using diethyl ether as a general anaesthetic. ... Routledge; London, UK, 2002. Snow SJ. Blessed Days of Anaesthesia: How Anaesthetics Changed
-
Grünenthal buys Zomig rights as AZ slimming drive continues
This work has seen it agree deals with TerSera Therapeutics ($320m for Zoladex), ProStakan ($70m for Moventig), Aspen ($770m for seven anaesthetics drugs) and, most recently, Recordati ($300m for two blood
-
J&J therapy for suicidal depressives 'a breakthrough', says FDA
Esketamine is a derivative of ketamine - arguably better known as a party drug but which has been used at high doses as an anaesthetic for decades - and is around twice as
More from news
Approximately 1 fully matching, plus 24 partially matching documents found.
Latest Intelligence
-
Deal Watch October 2016
200+. Janssen / J&J (US). Piramal (IN). Asset acquisition. 5 injectable pain / anaesthetic products.
-
Deal Watch September 2016
500. GSK / Aspen. Asset acquisition. Sale of anaesthetic drugs [Ultiva, Nimbex, Tracrium, Mivacron and Anectinein – excludes US/CA rights].
-
Deal Watch June 2016
Meanwhile AstraZeneca has out-licensed ex-US rights to a portfolio of seven anaesthetics to Aspen. ... Paying $520m upfront Aspen gains access to a series of local anaesthetics including Marcaine (bupivacaine) and Xylocaine (lidocaine/ lignocaine), and
-
Pharma deals in June 2015
Neosaxitoxin, novel anaesthetic for local anaesthesia and post-op pain management. Collaboration, licence.
-
Pharma deals during March 2014
Baxter's medical products business has annual sales of over $9bn and a portfolio of intravenous solutions and nutritional therapies, drug delivery systems, premixed and other injectable drugs, inhalation anaesthetics and
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Respiratory Analysers Market - In-Depth Market Research Report 2016 - 2026
Thus, respiratory analysers are absolutely critical as they measure various gases like Oxygen, Carbon Monoxide and volatile anaesthetics in the operation theatre.
-
It’s all about patient outcomes… right?
In late 1846, a dentist from New England, William TG Morton, is attributed to have performed a dental extraction using diethyl ether as a general anaesthetic. ... Routledge; London, UK, 2002. Snow SJ. Blessed Days of Anaesthesia: How Anaesthetics Changed
-
"Legal highs" ruling leaves illegal labs laughing
These include the anaesthetic nitrous oxide, or laughing gas. N2O has been used as a recreational drug since 1799, when 'laughing gas parties' were popular among the ruling classes.
-
"Legal highs" ruling leaves illegal labs laughing
These include the anaesthetic nitrous oxide, or laughing gas. N2O has been used as a recreational drug since 1799, when 'laughing gas parties' were popular among the ruling classes.
-
Hayward Medical Communications
Allergic Disorders. Anaesthetics. Anti-infectives. Cancer/oncology. Cardiovascular. Central nervous system (CNS). Contraception.
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
Featured jobs
-
Experienced Medical Writers
-
Competitive Salary and Benefits
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
- Account Manager- Healthcare Advertising
-
Negotiable
- Account Executive/ Senior Account Executive
-
competitive Salary Offfered
-
Associate Director
-
£75, 000-90, 000
-
Account Manager / Account Director
-
Competative
-
Medical Writer
-
Bonus Scheme, PTO &Private Healthcare
-
Account Director
-
Competitive Salary Offered
- Business Development Director – Health Education
-
excellent commission
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Senior Account Manager
-
Competitive Salary Offered
- Account Manager- Healthcare Advertising
-
Negotiable
Subscribe to our email news alerts
- Industry frustrated by late warning on 'no deal' Brexit disruption
- UK’s genomics leadership attracts IQVIA investment, regardless of Brexit
- Lucid Group celebrate another magical year at their Winter Meeting
- Biogen picks up another drug from wide-ranging Ionis alliance
- As France protests, Sanofi takes axe to 670 jobs
- Leicester NHS Trust’s staff intranet is integral to HCPs’ working day
PMHub
Swordfish Advertising
At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...
Latest intelligence
- Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
- What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
- What everyone forgets about good organisational change in pharma
- Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
- Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
- Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...
Quick links
Infographics
